title: [The role of inositol deficiency in the etiology of polycystic ovary syndrome disorders].
abstract: Inositol acts as a second messenger in insulin signaling pathway Literature data suggest inositol deficiency in insulin-resistant women with the polycystic ovary syndrome. Supplementation of myo-inisitol decreases insulin resistance as it works as an insulin sensitizing agent. The positive role of myo-inositol in the treatment of polycystic ovary syndrome has been of increased evidence recently The present review presents the effects of myo-inositol on the ovarian, hormonal and metabolic parameters in women with PCOS.
authors: Zakład Zdrowia Prokreacyjnego IMiDz, Chorób Kobiecych i Ginekologii Onkologicznej CSK MSW w Warszawie, Polska. jakimiuk@yahoo.com
authors: Artur J
authors: AJ
authors: Jakimiuk
authors: Klinika Ginekologii i Ginekologii Onkologicznej Uniwersytetu Medycznego w Białymstoku, Polska.
authors: Jacek
authors: J
authors: Szamatowicz
mesh_terms: D001786:Blood Glucose / Q000187:drug effects; D005260:Female; D005492:Folic Acid / Q000627:therapeutic use; D005498:Follicular Phase / Q000187:drug effects; D006801:Humans; D007294:Inositol / Q000172:deficiency* / Q000627:therapeutic use*; D010053:Ovary / Q000187:drug effects*; D011085:Polycystic Ovary Syndrome / Q000188:drug therapy* / Q000209:etiology / Q000378:metabolism* / Q000517:prevention & control; D016032:Randomized Controlled Trials as Topic; D014803:Vitamin B Complex / Q000627:therapeutic use*; D016387:Women's Health
chemical_list: D001786:Blood Glucose; D014803:Vitamin B Complex; D007294:Inositol; D005492:Folic Acid